Page last updated: 2024-11-06

prednisolone and Progeria

prednisolone has been researched along with Progeria in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Progeria: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kovina, MV1
Khavinson, VKh1
Strekalov, DL1
Solov'eva, DV1
Vorobtsova, IE1
Terekhov, SM1
Pleskach, NM1
Prokof'eva, VV1
Spivak, IM1
Timonina, GA1
Mikhel'son, VM1

Other Studies

1 other study available for prednisolone and Progeria

ArticleYear
[Cytological and molecular changes in the atypical case of accelerated human aging].
    Tsitologiia, 2002, Volume: 44, Issue:10

    Topics: Adult; Aging; Anti-Inflammatory Agents; Cell Division; Cutis Laxa; Diagnosis, Differential; Fibrobla

2002